Current Challenges and Opportunities in PD

Philip Kam-Tao Li1, Vickie Wai-Ki Kwong1

  • 1CUHK Carol and Richard Yu PD Research Centre, Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong.

Seminars in Nephrology
|February 4, 2017
PubMed

Insights

Peritoneal dialysis (PD) offers renal replacement therapy but faces challenges like infections and technique failure. Further research and global guidelines can improve PD patient outcomes.

Area of Science:

  • Nephrology
  • Renal Replacement Therapy

Background:

  • Peritoneal dialysis (PD) is increasingly used globally.
  • Significant challenges impede long-term PD success and patient outcomes.

Purpose of the Study:

  • To identify and address key areas needing improvement in peritoneal dialysis.
  • To highlight strategies for enhancing PD patient care and outcomes.

Main Methods:

  • Review of current challenges in PD.
  • Discussion of potential solutions including research, education, and guidelines.

Main Results:

  • Identified challenges include technique failure, infections, malnutrition, cardiovascular issues, volume overload, glucose exposure, solute removal adequacy, peritoneal access, physiological changes, patient fatigue, psychosocial factors, and elderly care.
  • Hemodialysis also presents areas for improvement.

Conclusions:

  • Continued clinical and basic science research is crucial.
  • Enhanced education, training, and global PD guidelines are essential for resolving PD challenges.
  • Improved PD patient outcomes are anticipated with these advancements.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.9K
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
353
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K